Form 4: Twist Bioscience Director Jan Johannessen Reports Acquisition of Common Stock

Director Jan Johannessen reports acquiring 4,472 shares of Twist Bioscience common stock on February 5, 2025, through an equity award.

Summary

• On February 5, 2025, Jan Johannessen, a director of Twist Bioscience Corp, acquired 4,472 shares of common stock.
• The acquisition was part of an annual equity award.
• The price per share was $0.
• Following the transaction, Johannessen directly owns 21,903 shares of Twist Bioscience common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates